McNeil Consumer Healthcare, Abbott Laboratories and Baxter Healthcare have joined the charity Direct Relief International to help stop the spread of dengue fever in Bolivia.
McNeil Consumer Healthcare, Abbott Laboratories and Baxter Healthcare have joined the charity Direct Relief International to help stop the spread of dengue fever in Bolivia.
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The US FDA approved Blujepa for the treatment of uncomplicated urinary tract infections, marking the first new mechanism of action for the infection in more than 30 years.
Professor Anil Koul shares vignettes of his life and career trajectory, a captivating mix of hope, science and destiny that took him to the lab of eminent cancer biologist Alex Ullrich at the Max Planck Institute and also saw him contribute to the development of breakthrough TB drug bedaquiline. He also talks about Medicine 3.0 and the intersection of science and spirituality.
The company is developing doravirine and islatravir together as an alternative to therapies containing integrase inhibitors, like Biktarvy, especially as HIV patients age.
The two companies were among those presenting data at CROI that highlighted the next frontiers of competition in the HIV space.
Adstiladrin sales hit €70m in first full year on the market
ICER’s new white paper pointed to estimates that the GLP-1 drugs may result in more than $100bn in annual spending, highlighting the need to rein in costs.
The company announced positive Phase IIb data for Descartes-08 in myasthenia gravis, with especially strong efficacy among patients without prior biologic treatment.
